These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26417858)

  • 41. The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer.
    Hu H; Hang JJ; Han T; Zhuo M; Jiao F; Wang LW
    Tumour Biol; 2016 Jul; 37(7):8657-64. PubMed ID: 26738860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pathologic characteristics and evaluation of the pancreatic cancer].
    Fukushima N; Mukai K
    Gan To Kagaku Ryoho; 2005 May; 32(5):599-604. PubMed ID: 15918557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma.
    Stracquadanio G; Vrugt B; Flury R; Schraml P; Würl P; Müller TH; Knippschild U; Henne-Bruns D; Breitenstein S; Clavien PA; Graf R; Bond GL; Grochola LF
    Clin Cancer Res; 2016 Dec; 22(24):6069-6077. PubMed ID: 27283965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Radiological evaluation of pancreatic ductal adenocarcinoma].
    Akai H; Otomo K
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):342-6. PubMed ID: 22421758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pancreatic cancer microenvironment.
    Kleeff J; Beckhove P; Esposito I; Herzig S; Huber PE; Löhr JM; Friess H
    Int J Cancer; 2007 Aug; 121(4):699-705. PubMed ID: 17534898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relating pancreatic ductal adenocarcinoma tumor samples and cell lines using gene expression data in translational research.
    Shuaichen L; Guangyi W
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):157-162. PubMed ID: 29729710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report.
    Ottenhof NA; de Wilde RF; Morsink FH; de Leng WW; Ausems MG; Morreau H; van Hillegersberg R; Offerhaus GJ; Milne AN
    Hum Pathol; 2012 Mar; 43(3):457-61. PubMed ID: 21992816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma.
    Kelly PJ; Shinagare S; Sainani N; Hong X; Ferrone C; Yilmaz O; Fernández-del Castillo C; Lauwers GY; Deshpande V
    Am J Surg Pathol; 2012 May; 36(5):696-701. PubMed ID: 22367300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyaluronan stimulates pancreatic cancer cell motility.
    Cheng XB; Kohi S; Koga A; Hirata K; Sato N
    Oncotarget; 2016 Jan; 7(4):4829-40. PubMed ID: 26684359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pancreatic ductal carcinoma: from the bench to the bedside.
    Pezzilli R
    JOP; 2006 Sep; 7(5):508-10. PubMed ID: 16998251
    [No Abstract]   [Full Text] [Related]  

  • 52. Where and when does pancreatic carcinoma start?
    Lüttges J; Hahn S; Klöppel G
    Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The distribution and role of myofibroblasts and CD34-positive stromal cells in normal pancreas and various pancreatic lesions.
    Kuroda N; Toi M; Nakayama H; Miyazaki E; Yamamoto M; Hayashi Y; Hiroi M; Enzan H
    Histol Histopathol; 2004 Jan; 19(1):59-67. PubMed ID: 14702172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting stromal metabolism in pancreatic ductal adenocarcinoma.
    Yin M; Lei QY
    Nat Cell Biol; 2024 Apr; 26(4):514-515. PubMed ID: 38429477
    [No Abstract]   [Full Text] [Related]  

  • 55. The cis-regulatory switchboard of pancreatic ductal cancer.
    Ferrer J; Real FX
    EMBO J; 2016 Mar; 35(6):558-60. PubMed ID: 26893390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microbial signatures in pancreatic cancer.
    Kotsiliti E
    Nat Rev Gastroenterol Hepatol; 2022 Jun; 19(6):350. PubMed ID: 35505242
    [No Abstract]   [Full Text] [Related]  

  • 57. Pancreatic cancer: Stromal-cancer cell crosstalk supports tumour metabolism.
    Dickson I
    Nat Rev Gastroenterol Hepatol; 2016 Oct; 13(10):558-9. PubMed ID: 27555474
    [No Abstract]   [Full Text] [Related]  

  • 58. Subtyping Pancreatic Cancer.
    Biankin AV; Maitra A
    Cancer Cell; 2015 Oct; 28(4):411-413. PubMed ID: 26461089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pancreatic cancer: Classifying pancreatic cancer using gene expression profiling.
    Ayars M; Goggins M
    Nat Rev Gastroenterol Hepatol; 2015 Nov; 12(11):613-4. PubMed ID: 26484444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up.
    Perera RM; Bardeesy N
    Cancer Discov; 2015 Dec; 5(12):1247-61. PubMed ID: 26534901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.